Artemis Investment Management LLP
Position in GILD — Gilead Sciences, Inc.
CIK 1535385
EDINBURGH, X0
Position in GILD
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$7,381,174
+$665,824 QoQ
Shares Held
52,961
-3.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Artemis Investment Management LLP holds $1,107,485,466 across 8 Drug Manufacturers - General names. GILD ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,444,565 | $284,897,109 | |
| 2 | ABBV |
AbbVie Inc.
|
1,041,483 | $226,512,137 | |
| 3 | PFE |
Pfizer Inc
|
7,392,508 | $207,581,624 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,885,298 | $174,993,323 | |
| 5 | BIIB |
Biogen Inc.
|
571,571 | $104,786,111 | |
| 6 | LLY |
ELI LILLY & Co
|
92,854 | $85,404,323 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $15,929,665 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
52,961 | $7,381,174 |
All Filings in GILD
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,381,174 | 52,961 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $6,715,350 | 54,712 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $5,297,364 | 47,724 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,668,830 | 60,150 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $9,362,225 | 83,554 | Shares | Sole | 2025-04-24 | |
| 2023-12-31 | $37,067,340 | 457,565 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $57,391,599 | 765,834 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $77,394,850 | 1,004,215 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $59,367,358 | 715,528 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $9,440,151 | 109,961 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $7,265,663 | 117,777 | Shares | Sole | 2022-10-25 | |
| 2021-09-30 | $4,739,671 | 67,855 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $19,107,617 | 277,485 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $9,555,286 | 147,846 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $6,452,644 | 110,756 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $5,009,892 | 79,283 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $6,174,588 | 80,252 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $6,063,858 | 81,111 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||